NYSE · PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS · LARGE CAP
Eastman Chemical Co. EMN
19 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY16 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$8.8B
▼ 6.7% vs FY2024
Dividend streak
16 yrs
Raised every year since 2010
EPS · FY25
$4.10
Dividend / sh · FY25
$3.33
Payout · FY25
80%
ROE · FY25
8.1%
Net margin · FY25
5.4%
Dividend coverage
1.2×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 8.8B
Revenue, FY2025 · full 19-year series below
Revenue
Net income
5 cents of every revenue dollar became profit this year.
Per share
USD 4.10
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 1.2 times — the rest stayed in the company.
Profitability
8.1%
Return on equity, FY2025
ROE
Operating margin6.5%
Net margin5.4%
Return on assets3.2%
Each USD of equity produced 8 cents of profit this year.
Returned to shareholders
USD 381.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 381.0M
Net buybacks—
Share of profit80.4%
Consecutive raises16 years
USD 381.0M in dividends — 80% of the year's profit went back to shareholders.
Growth
+0.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−6.1%
+0.7%
−1.0%
+2.7%
Net income
−15.8%
−0.2%
−5.7%
+0.7%
EPS, diluted
−13.6%
+3.2%
−3.2%
+2.4%
Dividend / share
+2.7%
+4.5%
+7.2%
+9.2%
Returned to shareholders
+0.0%
+1.3%
+4.8%
+7.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.22B
Shares outstanding, FY2025
Change, 5 years+1.5%
Change, 10 years+3.2%
The share count grew 1% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 14.9B
total assets, end of FY2025
Total assetsUSD 14.9B
EquityUSD 6.0B
CashUSD 566.0M
Gross debtUSD 4.8B
Net debtUSD 4.2B
Current ratio1.37×
Net debt stands at 71% of equity.
History
19 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
Revenue $B
8.8
9.4
9.2
10.6
10.5
8.5
9.3
10.2
9.5
9.0
9.6
9.5
9.3
8.1
7.2
5.8
4.4
5.9
6.8
Operating income $B
0.6
1.1
1.1
1.0
1.1
0.5
0.9
1.3
1.3
1.0
1.4
1.2
1.9
0.8
0.9
0.8
0.3
0.6
0.5
EBITDA $B
1.1
1.6
1.6
1.5
1.6
1.1
1.5
1.9
1.9
1.6
2.0
1.6
2.3
1.2
1.2
1.1
0.6
·
·
Income tax $B
0.1
0.2
0.2
0.2
0.2
0.0
0.1
0.2
−0.1
0.2
0.3
0.2
0.5
0.2
0.3
0.2
0.1
0.1
0.1
Net income $B
0.5
0.9
0.9
0.8
0.9
0.5
0.8
1.1
1.4
0.9
0.8
0.8
1.2
0.4
0.6
0.4
0.1
0.3
0.3
EPS, diluted $
4.10
7.67
7.49
6.35
6.25
3.50
5.48
7.56
9.47
5.75
5.66
4.97
7.44
2.93
4.52
2.88
0.93
4.55
3.84
Dividend / sh $
3.33
3.26
3.18
3.07
2.83
2.67
2.52
2.30
2.09
1.89
1.66
1.45
1.25
1.08
0.99
0.90
0.88
·
·
Payout %
80
42
42
48
44
75
45
29
21
32
28
28
12
44
21
30
94
39
49
ROE %
8.1
16.1
16.9
14.6
14.6
8.0
12.9
19.3
27.9
20.2
22.8
20.6
34.6
18.2
36.9
27.1
8.9
19.0
14.4
Shares out B
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.22
0.21
0.20
0.19
0.19
0.19
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
72 of 72
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed